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Abstract
Background: It is well known that the microbiota of high-fat (HF) diet-induced obese mice differs from that of lean
mice, but to what extent, this difference reflects the obese state or the diet is unclear. To dissociate changes in the
gut microbiota associated with high HF feeding from those associated with obesity, we took advantage of the
different susceptibility of C57BL/6JBomTac (BL6) and 129S6/SvEvTac (Sv129) mice to diet-induced obesity and of
their different responses to inhibition of cyclooxygenase (COX) activity, where inhibition of COX activity in BL6 mice
prevents HF diet-induced obesity, but in Sv129 mice accentuates obesity.
Results: Using HiSeq-based whole genome sequencing, we identified taxonomic and functional differences in the
gut microbiota of the two mouse strains fed regular low-fat or HF diets with or without supplementation with the
COX-inhibitor, indomethacin. HF feeding rather than obesity development led to distinct changes in the gut
microbiota. We observed a robust increase in alpha diversity, gene count, abundance of genera known to be
butyrate producers, and abundance of genes involved in butyrate production in Sv129 mice compared to BL6 mice
fed either a LF or a HF diet. Conversely, the abundance of genes involved in propionate metabolism, associated
with increased energy harvest, was higher in BL6 mice than Sv129 mice.
Conclusions: The changes in the composition of the gut microbiota were predominantly driven by high-fat feeding
rather than reflecting the obese state of the mice. Differences in the abundance of butyrate and propionate producing
bacteria in the gut may at least in part contribute to the observed differences in obesity propensity in Sv129 and BL6 mice.
Keywords: C57BL/6J mice, 129S6/Sv mice, Obesity, High-fat feeding, Microbiota, Microbiome, Indomethacin
Background
Evidence has accumulated that the gut microbiota is
an important environmental factor contributing to
obesity by altering host energy harvest and storage
[1–4], and transplantation experiments where transfer
of “obese microbiota” induces fat mass accumulation
in recipient mice have underscored the importance of
microbiota composition in obesity development [1, 3, 5–9].
High-fat (HF) feeding and obesity were initially re-
ported to be associated with a lowered ratio of Bac-
teroidetes to Firmicutes, but this view has been
challenged by subsequent studies [2, 10]. Recent stud-
ies have further indicated that obesity is correlated
with decreased microbial diversity or richness [11–13].
The composition of the gut microbiota may, in part,
be modulated by the genetic background [14–16] also
illustrated by the alterations in the gut microbiota
profiles observed in TLR5 knockout mice [7], TLR2
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knockout mice [5], NOD mice [17], ob/ob mice [3],
and db/db mice [18, 19] compared with wild-type
mice. However, in these mouse models, altered feed
intake may also contribute to the observed changes in
the gut microbiota. Yet, in some cases, transplant-
ation of the microbiota from the knockout mice into
wild-type recipient mice conferred a phenotype simi-
lar to that of the donor [7]. Still, long-term habitual
dietary intake is thought to be one of the strongest
drivers of the gut microbial composition in humans
[20] as well as mice [21], and especially intake of fat
is a strong driver of changes in the gut microbiota
[15]. However, as the amount of fat also determines
obesity development, the commonly used models of
HF diet-induced obesity cannot distinguish whether
changes in the microbiota result from the obese state
or from HF feeding.
The obesity-prone C57BL/6JBomTac (BL6) mouse
strain and the obesity-resistant mouse strain 129S6/SvEv-
Tac (Sv129) are among some of the most commonly used
strains for studies on genetic and diet-induced obesity.
We have shown that inhibition of cyclooxygenase activity
accentuated HF feeding-induced obesity in the obesity-
resistant Sv129 mice by reducing diet-induced thermogen-
esis and induction of UCP1 expression in inguinal white
adipose tissue [22], whereas inhibition of cyclooxygenase
activity in the normally obesity-prone BL6 mice prevented
HF feeding-induced obesity [23].
To gain further insight into diet- and obesity-
associated changes in the gut microbiota, and to distin-
guish whether the observed changes resulted from the
obese state or the HF feeding, we took advantages of the
different susceptibility of these two mouse strains to
diet-induced obesity and of their different responses to
inhibition of cyclooxygenase activity. Our results indi-
cate that changes in gut microbiota largely reflect HF
feeding and not obesity.
Results
Experimental setup and construction of a gut
metagenome reference set
To distinguish changes in the gut microbiota that occur
in response to an obesogenic diet from changes due to
obesity development, we exploited the different propen-
sity of BL6 and Sv129 mice to develop diet-induced
obesity and their divergent responses to treatment with
the general cyclooxygenase inhibitor indomethacin. The
mice were maintained on a low-fat (LF) diet or fed a HF
diet supplemented (HFI) or not (HF) with indomethacin.
In agreement with earlier findings [22], inclusion of
indomethacin accentuated the high-fat diet-induced in-
crease in weight, white adipose tissue (WAT) mass, and
hypertrophy in Sv129 mice (Fig. 1). By contrast, indo-
methacin supplementation prevented high-fat diet-
induced increase in weight, WAT mass, and hypertrophy
in BL6 mice (Fig. 1) [23].
Bacterial DNA was isolated from fecal samples from
54 mice from the different groups (30 Sv129 mice: 10
fed the LF diet, 10 fed the HF diet, and 10 fed the HFI
diet ; 24 BL6 mice: 7 fed the LF diet, 8 fed the HF diet,
and 9 fed the HFI diet) and subjected to whole genome
sequencing (WGS) using the Illumina HiSeq2000 plat-
form [24]. In total, 200.91 Gb high-quality data were
generated with an average of 3.72 Gb (46.10 million
reads) per sample. We employed de novo assembly as
previously described [15] to generate a non-redundant
gene catalog containing 793,847 genes (Additional file 1:
Table S1). A rarefaction analysis revealed a curve ap-
proaching saturation with 45 samples, and ICE and
Chao 1 indices indicated that we captured 99.53% of the
total gut microbial genes in the cohort (Additional file 2:
Figure S1). We carried out taxonomical assignment and
functional annotation using the Integrated Microbial Ge-
nomes (IMG) database (v3.4) [25], the NR database (v3),
and KEGG [26] database (release 59.0), respectively.
6.53% of the genes in the catalog, which covered 14.85%
in gene abundance, could be annotated using the IMG
database, while 75.14% of the genes could be annotated
using the NR database. At the functional level, we iden-
tified 4846 KEGG orthologues (KOs) covering 46.43% of
genes. For each sample, an average of 46.9 ± 0.2% (mean
± s.e.m.) of genes could be annotated in the KEGG data-
base. The taxonomic and functional profiles were con-
structed by summarizing the relative abundance of
genes.
Diet-induced and strain-dependent changes in the gut
microbiota
Gene, genus, and KO profile-based principal coordinates
analysis (PCoA) (Fig. 2 and Additional file 3: Figure S2)
pointed to dietary fat content as the principal separating
factor (PC1) and strain-specific differences between
Sv129 and BL6 mice as the secondary separating factor
(PC2). The PCoA further demonstrated that there was
no significant separation between the HF- and the HFI-
fed mice based on the microbiome gene profiles (Fig. 2)
and by Wilcoxon rank-sum testing (Additional file 4:
Figure S3 and Additional file 5: Figure S4), despite a
clear effect of indomethacin on obesity development.
A PERMANOVA test similarly demonstrated that diet
had a larger impact on the gut microbiota than strain
and importantly that indomethacin supplementation did
not significantly affect the gut microbiota composition
at the gene level, the genus level, and the KEGG level
(Additional file 6: Table S2).
Comparison of the gut microbiomes of mice fed a LF
diet revealed significantly higher alpha diversity of the
samples from Sv129 mice than BL6 mice (Fig. 3a).
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Feeding the mice a HF diet led to a significantly in-
creased alpha diversity at both the gene and KO levels in
both strains with a relatively larger increase in BL6 mice.
As the increased alpha diversity was more pronounced
in BL6 mice, the difference in alpha diversity became
non-significant in HF-fed mice. Addition of indometh-
acin to the HF diet did not significantly influence alpha
diversity (Fig. 3a and Additional file 7: Figure S5). We
further investigated differences and similarity of the gene
distribution in the two mouse strains and how the HF
diet impacted on the composition of the gut microbiota.
Wilcoxon testing demonstrated that a large fraction of
the microbial genes (444,171; 60.18%) was found in simi-
lar relative abundance in both strains fed the LF diet.
202,729 (27.47%) of the genes had higher relative abun-
dance in LF-fed Sv129 mice than in LF-fed BL6 mice,
whereas 91,223 (12.36%) of the genes were present in
higher abundance in LF-fed BL6 mice. Of the genes that
were shared between the two mouse strain fed the LF
diet, 320,199 (72.09%) maintained the same relative
abundance in the two strains in response to HF feeding,
whereas 58,027 (13.06%) increased in the Sv129 mice
and 55,546 (12.51%) increased in the BL6 mice. 10,399
(2.34%) became undetectable after HF feeding. Of the
202,729 genes that were enriched in the LF-fed Sv129
mice, 122,577 (27.60%) were found in equal relative abun-
dance in Sv129 and BL6 mice after HF feeding, whereas
2866 (0.65%) became undetectable. Interestingly, a small
Fig. 1 Body weight gain, adipose tissue weight, and adipose tissue histology. a Body weight gain of Sv129 and BL mice fed low-fat (LF), high-fat
(HF), or HF + indomethacin (HFI) diets. b, c Tissue weights of epididymal (eWAT), inguinal (iWAT), retroperitoneal (rWAT), and interscapular brown
(iBAT) adipose depots in b Sv129 and c BL mice fed low-fat (LF), high-fat (HF), or HF + indomethacin (HFI) diets. Error bars represent s.e.m.. Shared
letters on the bars indicate P≥ 0.05, whereas different letters denote significant differences between the groups (<0.05), Kruskal-Wallis with Dunns
post hoc test. d Cumulative feed intake. e Energy efficiency. f Hematoxylin/eosin staining of iWAT tissues from Sv129 and BL mice fed LF, HF or
HFI diets. Scale bar = 50 μm
Xiao et al. Microbiome  (2017) 5:43 Page 3 of 12
subset of the genes 4693, 1.06%) enriched in Sv129 mice
on a LF diet became more abundant in the BL6 mice. Fi-
nally, of the 91,223 genes selectively enriched in the BL6
mice fed a LF diet, 41,458 (9.33%) were found I equal rela-
tive abundance after HF feeding in both strain, 45,087
(10.15%) remained more abundant in the BL6 mice,
whereas 3463 (0.78%) became more abundant in the
Sv129 mice. 1215 (0.27%) of the genes enriched in BL6
mice were undetectable after HF feeding (Additional
file 8: Figure S6).
Obesity has been reported to be associated with a de-
creased microbial gene count [11, 12]. In LF-fed mice,
the gene count was significantly higher in the Sv129
mice than in the BL6 mice (Fig. 3b). HF feeding with or
without indomethacin supplementation increased the
gene count in both strains. Thus, an increase in gene
count was observed in response to HF feeding irrespect-
ive of whether the mice remained lean or became obese.
Of note, after HF feeding, no significant difference in
gene count between the two strains was observed
(Fig. 3b).
Consumption of HF diets induced taxonomical
changes independently of strain and obesity develop-
ment. The Wilcoxon rank-sum test (P < 0.05) demon-
strated that the HF diet induced the same directional
changes in relative abundances of 89 out of 128 genera
(69.5%) in both mouse strains, whereas only 8 (6.3%) ex-
hibited changes exclusively in BL6 mice, and 11 (8.6%)
exhibited changes exclusively in Sv129 mice. The
remaining identified 20 genera (15%) were unchanged.
In keeping with previous observations [1–4, 27], the five
most abundant phyla in both Sv129 and BL6 mice in-
cluded Bacteroidetes, Firmicutes, Verrucomicrobiota, Pro-
teobacteria, and Actinobacteria, and HF feeding led to an
increased Firmicutes:Bacteroidetes ratio (Additional file 9:
Fig. 2 PCoA analysis of all the samples based on gene profiles. The
different colors and shapes designate samples from different subgroups,
while the empty, half-filled, and full-filled points correspond to mice
characterized as “lean,” or with “no significant increase in adipose tissue
mass (NSI),” and “significant increase adipose tissue mass (SI).” The
PCoA demonstrates how mouse strain and diet are main drivers for
separation at the gene level
Fig. 3 a Alpha diversity and b Gene count in relation to mouse
strain and diet. Alpha diversity was calculated based on the gene
profiles using the Shannon index. In mice fed a low-fat (LF) diet, Sv129
mice exhibited a significantly higher alpha diversity than BL6 mice. High-
fat (HF) diet increased alpha diversity of the gut microbiome significantly
in both strains of mice, so that no significant differences in alpha diversity
were observed after HF feeding. Supplementation with indomethacin
did not lead to significant changes of alpha diversity. Gene count in LF-
fed Sv129 mice was significantly higher than in BL6 mice. HF feeding led
to a significant increase in gene count in both mouse strains
and eliminated the difference in gene count observed in LF mice.
Statistical differences were analyzed by unpaired Wilcoxon rank-sum
test (with FDR correction). Statistically significant differences (P < 0.05)
between groups are denoted with different letters (a, b, c, d) on the
top of the graphic boxes. Boxes denote the interquartile range (IQR)
between the first and third quartiles (25th and 75th percentiles,
respectively) and the line inside denotes the median
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Figure S7). In mice fed a standard LF diet, Firmicutes were
present at a higher abundance in Sv129 than in BL6 mice,
but the abundance increased to similar levels after HF
feeding. Further, Verrucomicrobia were more abundant in
BL6 mice than in Sv129 mice, but no alterations in abun-
dance were observed in response to HF feeding (Add-
itional file 9: Figure S7). Of the less abundant phyla, we
observed a significant increase in relative abundance of
Spirochaetes, Fusobacteria, Synergistetes, and Euryarch-
aeota in response to HF feeding in both strains (Add-
itional file 10: Figure S8).
In agreement with previous studies [15], the five most
abundant genera in BL6 and Sv129 included Bacteroides,
Clostridium, Akkermansia, Roseburia, and Lactobacillus
(Additional file 5: Figure S4). In both BL6 and Sv129
mice, HF feeding decreased the relative abundance of
Bacteroides but increased the relative abundance of Clos-
tridium, Roseburia, and Lactobacillus (Additional file 5:
Figure S4). Of the less abundant genera, we noted dra-
matic decrease in the relative abundance of Tannerella,
Prevotella, and Parabacteroides in both strains in re-
sponse to HF feeding (Additional file 11: Figure S9). By
contrast, the relative abundance of Oscillibacter, Eubac-
terium, Ruminococcus, Pseudoflavonifractor, Blautia,
Dorea, Anaerotruncus, Subdoligranulum, and Faecali-
bacterium increased in response to HF feeding (Add-
itional file 11: Figure S9).
The most abundant identified species comprised
Akkermansia muciniphila, Lachnospiraceae bacter-
ium 3_57fAA_CT1, Tannerella sp. 6_1_58FAA_CT1,
Ruminococcaceae bacterium D16, and Oscillibacter
valericigenes (Additional file 12: Figure S10).
Changes in less abundant identified species are
shown in Additional file 13: Figure S11. Of note, the
relative abundance of A. muciniphila, reported to
maintain gut barrier function and associated with re-
sistance to diet-induced obesity [28], was surprisingly
lower in Sv129 than in BL6 mice on both LF and
HF diets (Additional file 12: Figure S10). Presently,
it is difficult to reconcile this finding with the con-
sistent observations that A. muciniphila seems to
protect against low-grade inflammation and diet-
induced obesity, but the increased abundance of A.
muciniphila may reflect a homeostatic response to
counteract low-grade inflammation in the obesity-
prone BL6 mice. We observed a striking decrease in the
relative abundance of Tannerella sp. 6_1_58FAA_CT1 in
response to HF diets in both Sv129 and BL6 mice (Add-
itional file 12: Figure S10).
Genera selectively enriched in the Sv129 and BL6 mice
and diet-induced functional changes of the microbiota
To further characterize the microbiota of the two mouse
strains, we identified genera with higher abundance in
each of the strains, and co-occurrence networks in each
strain fed the LF diet (P < 0.05) (Fig. 4). Clostridium and
Roseburia were found enriched in Sv129 mice, and these
two genera are reported as butyrate-producing bacteria
[29] suggesting that the potential for butyrate formation
was selectively enriched in Sv129 mice. The butyryl-CoA
transferase (BCT), catalyzing the last step in the pathway
leading to butyrate formation, can be used as a gene
Fig. 4 Network of the genera characterizing Sv129 and BL6 mice. The green circles represent genera present in higher abundance in Sv129 mice than
in BL6 and red circles genera present in higher abundance in BL6 mice than in Sv129. The area of the circle represents the relative abundance of the
genus. The solid line represents a positive correlation between two genera, while a dashed line represents a negative correlation
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marker for butyrate production [30]. To further examine
butyrate formation potential, we examined the relative
abundance of the gene encoding the BCT enzyme [31]
in Sv129 and BL6 mice.
In our gene catalog, we identified 12 genes matching
the BCT sequence using BLAST using thresholds of 70%
identity and 70% coverage at the amino acid sequence
level. The relative abundance of these 12 genes was sum-
marized as a proxy representing butyrate formation cap-
acity (Fig. 5a), which indicated that the abundance of
BCT was significantly higher in Sv129 mice than in BL6
mice, but in both stains, the abundance of BCT unex-
pectedly increased when the mice were fed HF diets. To
further analyze the potential capacity for butyrate
production, we defined a butyrate formation module in-
cluding enzymes catalyzing 8 reactions from acetyl-CoA
to butyrate (Fig. 5b). The relative abundance of the 11
KOs comprising this module was calculated according
to the different subgroups. In line with the results shown
in Fig. 5b, the relative abundance of KOs comprising this
butyrate formation module was higher in Sv129 mice
than in BL6 mice (Additional file 14: Figure S12). This
suggests that differences in butyrate production of the
gut microbiota in Sv129 and BL6 mice might contribute
to the different phenotypes in relation to obesity propen-
sity. We used a previously reported z score method [32]
to further analyze diet-dependent differences between
the two strains at the functional level. Main differences
are listed in Additional file 15: Table S3. These analyses
indicated that the metabolism of short chain fatty acids
(SCFAs) was differently affected by the HF diet in the
two strains. In keeping with results on the potential for
butyrate production, HF feeding was associated with a
general increase in the abundance of genes involved in
butyrate metabolism in both strains (Additional file 14:
Figure S12), whereas the abundance of genes involved in
propionate metabolism module, associated with in-
creased energy harvest, increased in BL6 mice in re-
sponse to HF feeding (Additional file 15: Table S3),
possibly at least in part contributing to the sensitivity of
the BL6 strain to HF diets. Still, in relation to obesity
propensity, more experiments are clearly needed to ex-
plain the increase in the abundance of BCT in response
to HF feeding.
KEGG level 1 pathway analyses revealed additional HF
diet-induced changes, independent of strain and obesity.
The relative abundance of KOs associated with cellular
processes and environmental information processes in-
creased after HF diet feeding, while the abundance of
KO associated with general metabolism declined (Add-
itional file 4: Figure S3). To further analyze the affected
metabolic pathways, we used z score method [32] for
functional analysis at the level of pathways and modules
followed by detailed analysis of KO changes in each se-
lected pathway and module. Independent of mouse
strain, HF feeding increased the abundance of genes in-
volved in pathways and modules related to fatty acid me-
tabolism, cell mobility, transport, methane metabolism,
and xenobiotic degradation, as well as decreases in the
abundance of genes involved in translation and vitamin
biosynthesis (Additional file 16: Table S4 and Additional
file 17: Table S5).
Utilization of the glycerol moiety of the triglycerides is
required to extract energy from triglycerides in HF diets
in an anaerobic environment. To investigate if the gut
microbiota adapts to increased glycerol utilization in re-
sponse to a HF diet, we used KEGG and NCBI to search
for the key enzyme in glycerol utilization, glycerol
Fig. 5 Relative abundance of butyryl-CoA transferase related genes
in Sv129 and BL6 mice and pathways catalyzing conversion of
acetyl-CoA to butyrate. a The relative abundance of butyryl-CoA
transferase genes was higher in Sv129 than BL6 mice. Of note, HF
feeding increased the relative abundance of butyryl-CoA transferase
genes in both strains. Statistical differences were analyzed by unpaired
Wilcoxon rank-sum test (with FDR correction). Statistically significant
differences (P < 0.05) between groups are denoted with different
letters (a, b, c, d) on the top of the graphic boxes. b The pathways
catalyzing conversion of acetyl-CoA to butyrate comprise eight
enzymatic reactions, and the numbers of the enzymes catalyzing
these reactions in Sv129 and BL6 mice are marked in different
colors, Sv129 in blue, and BL6 in red. The number of the enzymes
included in this pathway module is markedly higher in Sv129 mice
than in BL6 mice
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kinase, in the most abundant genera. Of note, glycerol
kinase was found in 18 of the 25 most abundant genera
(Additional file 18: Table S6). Moreover, the majority of
genera possessing genes encoding glycerol kinase was
enriched in mice fed HF diets, whereas genera unable to
utilize glycerol were enriched in low-fat diet-fed mice
(Additional file 18: Table S6). Together, this suggests
that increased capacity for glycerol utilization character-
izes HF diet-induced changes in the gut microbiota in
both mouse strains.
Bile acids play an important role in fat metabolism in
the intestine, and HF feeding may lead to an increased
requirement for bile acid 7α-dehydroxylation. Accord-
ingly, reads classified as Clostridium scindens, Clostrid-
ium hiranonis, Clostridium hylemonae, and Clostridium
leptum, all reported to accelerate bile acid 7α-
dehydroxylation [33, 34], were found in higher abun-
dances after HF feeding (Additional file 19: Figure S13).
Furthermore, the relative abundance of the Clostridium
genus was increased in both mouse strains in response
to HF diet (Additional file 5: Figure S4).
Discussion
Human cross-sectional studies and animal studies have
demonstrated that the gut microbiota of obese individ-
uals differs from that of lean individuals and also show
that diet strongly influences the composition of the gut
microbiota. Still, these studies do not allow to clearly de-
termine whether the different composition of the gut
microbiota is a cause or a consequence of the obese state
even though transplantation experiments have demon-
strated that an “obese” microbiota may precipitate obes-
ity in the recipient. In this study, the divergent effect of
HF diets with and without indomethacin in BL6 and
Sv129 mice allowed us to separate alterations in the gut
microbiota induced by the change from a LF diet to a
HF diet from alterations elicited by obesity showing that
the changes in gut microbiota reflected an effect of HF
feeding and not of obesity. This finding is in agreement
with an earlier study using 16S rRNA gene amplicon se-
quencing to compare the effect of HF feeding on RELM
knockout and wild-type mice on a mixed 129Svev/
C57BL/6 background, namely that HF feeding and not
obesity is the driver of the changes in the composition
of the gut microbiota [35]. A similar conclusion was
reached by Clavel et al. based on fluorescence in situ
hybridization [36]. Our study adds to these finding by
providing more detailed information at the gene level
using metagenomic whole genome sequencing.
In rats, it has been reported that treatment with indo-
methacin was associated with changes in the gut micro-
biota, including gain of Enterococcus faecalis-related
bacteria and loss of segmented filamentous bacteria [37].
However, our results (Additional file 20: Figure S14)
revealed no significant changes in the composition of E.
faecalis-related bacteria in mice fed a HF diet supple-
mented with indomethacin. This difference between
mice and rats may in part be related to the absence of a
gall bladder in rats, but obviously, other species-related
differences may play a role. A recent study reported on
the acute and chronic effects of indomethacin supple-
mentation in BL6 mice based on 16S ribosomal RNA
(rRNA) gene amplicon sequencing [38]. Using an acute
dose about 10 times higher than the dosage used in the
present experiments, the authors found that the abun-
dance of Peptococcaceae in the fecal samples increased
already after 6 h. Exposure for 7 days using a dosage
similar to the one used here resulted in no significant
changes in the fecal microbiome, whereas an increased
abundance of Peptococcaceas was observed in samples
from cecum and the large intestine [38]. This finding
and the clear effects of the microbiota on the metabol-
ism of indomethacin suggest that some of the strain-
specific effects of indomethacin supplementation may
relate to differences in composition of the microbiota
and changes in the gut not reflected in fecal samples.
Comparison between the microbiota of the obesity-
prone BL6 and the obesity-resistant Sv129 mice revealed
that Sv129 mice had higher gene count than BL6 mice
(Fig. 3b). Low gene count has been associated with a
more obese and inflamed phenotype in mice and
humans [12, 39]. Furthermore, a decline in the abun-
dance of genes involved in butyrate production has been
noted as a common feature of low gene count obese in-
dividuals [12] as well as in type 2 diabetic Han Chinese
[40], and a generally reduced potential for butyrate pro-
duction in the gut microbiota has been associated with a
number of human diseases [41]. Interestingly, dietary in-
take of high amounts of butyrate has been reported to
improve insulin sensitivity and counteract HF diet-
induced obesity [42, 43], but whether gut microbial syn-
thesis can raise butyrate levels in circulation to the same
degree remains questionable. To add to the complexity
of the effects of butyrate on obesity development, butyr-
ate production was initially associated with increased en-
ergy harvest from the gut and obesity [3], and increased
production of butyrate has been reported in obese indi-
vidual [10]. Yet, analysis of the potential for butyrate
production in the gut microbiota of Sv129 and BL6 mice
demonstrated that the obesity-resistant Sv129 mice har-
bored a gut microbiota with a potentially higher capacity
for butyrate production than the obesity-prone BL6
mice. Thus, the relative abundance of the genes encod-
ing the enzyme catalyzing the last step leading to butyr-
ate formation, BCT, was significantly higher in Sv129
mice than in BL6 mice. Furthermore, by defining a bu-
tyrate formation module including enzymes catalyzing
eight reactions from acetyl-CoA to butyrate, we
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demonstrated that the relative abundance of the genes
comprising this module was higher in Sv129 mice than
BL6 mice. This suggests that differences in butyrate pro-
duction in the gut of Sv129 and BL6 mice may contrib-
ute to the different phenotypes in relation to obesity
propensity. However, our finding that the abundance of
BCT increased in response to HF feeding clearly indi-
cates that more experiments are needed to provide a
comprehensive understanding of the role of butyrate
production in obesity development.
In mice fed a LF diet, we noted characteristic differ-
ences between Sv129 and BL6 mice. Whereas Firmicutes
were present at a higher abundance in Sv129 than in
BL6 mice, Verrucomicrobia were more abundant in BL6
mice than in Sv129 mice. Surprisingly, we observed that
the relative abundance of A. muciniphila, reported to
maintain gut barrier function and associated with resist-
ance to diet-induced obesity [28], was lower in the
obesity-resistant Sv129 than in BL6 mice on both LF and
HF diets. This finding underscores that even though
colonization by this bacterium is reported to counteract
diet-induced obesity [28, 44, 45], the function of this
bacterium may well depend on a specific community en-
vironment, as also indicated by the large differences in
the relative abundance of A. muciniphila in fecal sam-
ples from mice kept in different housing facilities [15].
Extraction of energy from triglycerides in an anaerobic
environment depends on the metabolism of glycerol.
Using KEGG and NCBI to search for key enzymes in
glycerol utilization in the most abundant genera, we
found that the genes encoding glycerol kinases, acylgly-
cerol kinase, or diacylglycerol kinase were found in 10 of
the 25 most abundant genera, and 8 of these genera
were enriched in mice fed HF diets whereas genera un-
able to utilize glycerol were enriched in mice fed the
low-fat diet. This suggests that such adaptation contrib-
utes to the strain-independent HF diet-induced changes
in the gut microbiota. Similarly, HF feeding led to an in-
crease in the abundance of Clostridium species reported
to accelerate bile acid 7α-dehydroxylation [33, 34], may
be associated with a need for bile acid metabolism in re-
sponse to the intake of a diet high in triglycerides, but
more work is clearly needed to establish whether HF
feeding alter bile acid metabolism.
Conclusions
This study demonstrates that ingestion of a HF diet is a
major driver of changes in the gut microbiota in mice,
irrespective of whether or not the mice develop obesity.
Of note, the gene count in LF diet-fed Sv129 mice was
higher than that of BL6 mice. Compared with BL6 mice,
the microbiome of Sv129 mice have a higher abundance
of genes involved in butyrate production. Butyrate plays
a key role in gut health and low gene count obese
individuals, and type 2 diabetic patients seem to have
less potential for butyrate production than high gene
count [12, 40]. Thus, our findings suggest that differ-
ences in the capacity for butyrate production between
Sv129 mice than in BL6 may contribute to the different
propensity of these two mouse strains to develop diet-
induced obesity. However, further analyses of the actual
production of butyrate in the gut and levels of butyrate
in circulation are needed to corroborate this notion. In a
broader sense, our findings open the possibility that
changes in caloric intake/fat intake associated with both
diet-induced and genetically dependent obesity may be
the driver for the observed changes in the gut micro-
biota, and that such diet-dependent changes subse-
quently in transplantation experiments may confer the
obese phenotype. While differences in the gut micro-
biota may contribute to the different propensity for
obesity development in the two mouse strains, differ-
ences in the genetic make-up of these two strains may
also play a role, directly or indirectly via effects on the
composition of the gut microbiota.
Methods
Test compounds and diets
Low-fat (Ssniff EF R/M control) and high-fat (Ssniff EF
R/M acc D12492) diets were obtained from Ssniff Spe-
zialdiäten GmbH (Germany). The low-fat (LF) diet con-
tained 70 energy (e)% carbohydrates, 20 e% protein, and
10 e% fat, and the high-fat (HF) diet contained 21 e%
carbohydrates, 19 e% protein, and 60 e% fat. For the HF
diet supplemented with indomethacin (HFI), 0.0016 g/
100 g was included in the diet.
Animals and housing
Twenty-four male C57BL/6JBomTac and 30 male
129S6/SvEvTac mice, 10 weeks old, were obtained from
Taconic (Ry, Denmark). All mice were individually caged
with sawdust bedding, kept under controlled environ-
mental conditions (temperature 26 ± 0.5 °C, 12/12-h
light/dark cycle), and had free access to feed and water.
After 1 week of acclimatization, mice of each strain
were placed in three groups (10 LF-, 10 HF-, and 10
HFI-fed Sv129 mice; 7 LF-, 8 HF- and 9 HFI-fed BL6
mice) and fed these different diets for 6 consecutive
weeks. Body weight was recorded twice a week, and feed
intake was recorded weekly. All mice were observed at
least twice a day for any abnormalities in clinical appear-
ance. At the end of the experiment, mice were anesthe-
tized with isoflurane (Isoba-vet, Schering-Plough,
Denmark) and euthanized by cardiac puncture. Relevant
adipose tissues were immediately dissected, weighed,
flash-frozen in liquid nitrogen, and stored at −80 °C.
The animal experiment was approved by the National
State Board of Biological Experiments with Living
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Animals (Norway and Denmark) and carried out in ac-
cordance with the approved guidelines.
DNA extraction
Fresh feces was sampled before the termination and im-
mediately frozen at −80 °C. DNA extractions were per-
formed on 200 mg of feces per sample using the
Macherey-Nagel Nucleospin Soil kit. Extractions were
carried out according to the kit protocol except that cell
lysis was done by bead beating the samples two times
for 30 s with incubation for 2 min on ice between the
bead beatings. The resulting concentrations of genomic
DNA were measured by nanodrop, and DNA integrity
examined by agarose gel electrophoresis. Metagenomic
sequencing was conducted using HiSeq 2000 and 90-bp
PE strategy [24].
De novo assembly and gene prediction
After removing adapters, low-quality reads and reads
that belong to the host were removed, 46,100,196 ±
977,672 (mean ± s.e.m.) high-quality reads were ob-
tained. These high-quality reads from the 54 samples
were then assembled to contigs using SOAPdenovo
(v1.06) by employing the same parameters that were
used in MetaHIT gene catalog [24]. For each sample,
53,226 ± 2,097 (mean ± s.e.m.) contigs were obtained
with a length 102,946,516 ± 2,678,730 bp (mean ± s.e.m.).
GeneMark (v2.7) was employed to predict open reading
frames (ORFs).
Construction of a gut metagenome reference
To explore the metagenomic information of the mouse
gut microbiota, we first generated a metagenomic cata-
log based on the samples obtained in the present study.
All ORFs predicted from the 54 samples were merged
and aligned to each other using BLAT. Gene pairs with
greater than 95% identity (no gap allowed) and aligned
reads covering over 90% of the shorter reads were
grouped together. The longest ORF in each group was
used to represent the group, and the other ORFs of the
group were regarded as redundant sequences. ORFs with
a length less than 100 bp were subsequently filtered out.
Finally, a gene catalog containing 793,847 non-
redundant genes was constructed, covering 77.4 ± 0.3%
(mean ± s.e.m.) of the high-quality reads in each sample.
Based on this reference gene set, we carried out taxo-
nomical assignment and functional annotation using the
NR database (v3) and the KEGG database (release 59.0).
In this study, 80% of the genes in the catalog could be
robustly assigned to the NR database, the remaining
genes were likely to be from currently undefined micro-
bial species. At the functional level, we identified 4846
KEGG orthologues (KOs), covering 46.43% of the genes
in the catalog.
Taxonomical assignment and functional classification
The nucleotide sequences of predicted genes were trans-
lated into protein sequences using the NCBI Genetic
Codes 11. BLASTp was employed to conduct the taxo-
nomical assignment and functional classification of pre-
dicted genes against the NR database (v3) and KEGG
database (release 59.0) with E value ≤1 × 10−3. All genes
were searched against IMG (v3.4) with BALSTN using
default parameters except that the E value was set to 1 ×
10−5. The taxonomical association of a gene was decided
by the lowest common ancestor of all its taxonomical
annotation results. Genes annotated by KEGG were
assigned to KEGG pathways. In total, we identified 4846
KOs in the reference gene set with 80.0 and 46.4% genes
of reference gene set having taxonomical and functional
information, respectively.
Relative abundance of genes and KOs
The high-quality clean paired-end reads from each sam-
ple were aligned against the reference genes set by
SOAP2 using a criterion requiring an identity >90%. We
only counted the number of reads which fulfilled the fol-
lowing criteria: (i) Paired-end reads could be mapped
onto the gene sequence with a moderate insert-size; (ii)
One of the paired-end reads could be mapped onto the
end of gene sequence, while the other reads mapped
outside the gene region. In both situations, the mapped
paired-end reads were counted as one copy. The number
of reads mapped onto a certain gene was normalized by
the gene length. Subsequently, the relative abundance
table was constructed by normalizing the sum of all
genes of a sample to 1. In Eq. (1), xi designates the num-
ber of reads that mapped onto a certain gene, and Li the
length of that gene, then the relative abundance of that








where j runs through the whole reference gene set.
All samples were treated in the same way resulting in
a table containing the relative abundance of all genes of
all samples. The KO profile was derived by summing up
the relative abundance of genes which aligned to the
same KO. As the same gene could belong to more than
one KO group, we included the relative abundance of
these genes in all the KO’s.
Biodiversity analysis
Shannon index and Sørensen-Dice similarity index were
calculated based on the relative abundance table of the
54 samples.
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Statistical analysis
All statistical analyses were implemented by the R soft-
ware. Principal coordinates analysis (PCoA) was imple-
mented using the “ade4” package [46]. To equalize the
relative importance of common and rare genes/species/
KOs, square root transformation was performed before
PCA. Wilcoxon rank-sum test was employed to do the
comparison analysis. Pair-wise Wilcoxon rank-sum test
was used to do the difference comparison among experi-
mental groups, in which the Hommel’s method was used





The definition of effect size used in functional analysis
is demonstrated in the Eq. (2), where Abundi is the aver-
age function abundance of experimental group i . Pear-
son correlation coefficient was used to measure the
correlation between two features. The significance level
was set to 0.05.
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significant differences (P < 0.05) between groups are denoted with
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the top of the graphic boxes. (PDF 941 kb)
Additional file 15: Table S3. Strain specific fucntion changes
responding to high-fat diet. (XLS 26 kb)
Additional file 16: Table S4. Diet-induced changes in pathway. (XLS 9 kb)
Xiao et al. Microbiome  (2017) 5:43 Page 10 of 12
Additional file 17: Table S5. Diet-induced changes in module. (XLS 8 kb)
Additional file 18: Table S6. Consistence of HF enrichment and
existence of glycerol kinase. (XLS 43 kb)
Additional file 19: Figure S13. Relative abundance of bile acid
metabolizing bacteria. Clostridium hylemonae, Clostridium leptum,
Clostridium scindens, and Clostridium hiranonis have been associated with
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